Pharmaceutical company to pay nearly $340 millions for falsely promoting meds that led to increased opioid crisis
California Attorney General Rob Bonta has secured a settlement with pharmaceutical behemoth Mylan Inc., therefore promising up to $335 million in reparations, a major step toward solving the national opioid issue. Reached with a coalition of nonpartisan attorneys general from around the United States, this settlement seeks to hold the corporation responsible for its involvement in the opioid crisis.
Mylan, a company that has been essential to the opioid business since 2005, merged with Viatris in past years. It has manufactured and sold several opioids, including generic versions of fentanyl patches, oxycodone, hydrocodone, and buprenorphine.
The lawsuits against Mylan, meanwhile, focused on claims that the corporation falsely marketed these medications as less prone to misuse. State prosecutors argued, however, that Mylan was aware these drugs, particularly the fentanyl patches, were more prone to misuse.
Read also: Gov. Newsom wants to avoid Trump admin tariffs with direct partnerships with select countries
The false advertising strategies mentioned in the complaint imply that Mylan forcefully promoted these opioids to doctors, hence supporting a trend of overprescription. This overprescription has been a major factor in the spread of addiction and has facilitated the diversion of drugs into the black market, exacerbating the opioid crisis across communities in the United States.
“Companies and individuals who fueled the opioid crisis must be held accountable. With today’s announcement, the California Department of Justice is continuing to deliver results,” said Attorney General Bonta. “The opioid crisis does not distinguish between Democrats or Republicans – it has affected people from all walks of life. I’m proud to have worked on this with a bipartisan coalition of attorneys general.”
Providing important money to help fight the opioid crisis, the $335 million settlement will be paid out over the following nine years. The money is meant for recovery programs, preventive plans, and other projects meant to reduce opioid abuse and addiction.
This settlement came from collaborative negotiations which includes the attorneys general from nine states—California, Illinois, Massachusetts, New York, North Carolina, Oregon, Tennessee, Utah, and Virginia. The initiatives also involved cooperation with Colorado, Delaware, Georgia, Idaho, Iowa, and Vermont, so highlighting a unified front in addressing an emergency affecting millions more and claiming thousands of lives.
Read also: California AG Rob Bonta celebrates yet another huge legal win against the Trump administration
The agreement with Mylan reflects state officials’ ongoing effort to challenge the pharmaceutical sector’s part in the opioid crisis. It follows a slew of settlements and lawsuits that have drawn more and more attention to how medications are marketed and prescribed in the United States. This case against Mylan adds another dimension to the continuing legal and moral struggle to tackle the underlying reasons of opioid addiction and guarantee that such a public health crisis does not recur.
